Dynavax Technologies reported $21.08M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Adma Biologics ADMA:US $ 13.24M 965.23K
Agenus AGEN:US $ 16.65M 298K
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Astrazeneca AZN:US 2.57B 76M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
BioSpecifics Technologies BSTC:US 3.06M 929.38K
Bristol Myers Squibb BMY:US $ 1.88B 215M
Chimerix CMRX:US 4.41M 272K
Dynavax Technologies DVAX:US $ 21.08M 862K
Gilead Sciences GILD:US $ 1.34B 297M
Glaxosmithkline GSK:US 2.5B 183M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Idera Pharmaceuticals IDRA:US $ 2.47M 684K
Merk MRK:US $ 2.25B 376M
Minerva Neurosciences NERV:US $ 3.44M 806.44K
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Tg Therapeutics TGTX:US $ 34.02M 7.26M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M